Intravenous Magnesium Sulphate for Aneurysmal Subarachnoid Hemorrhage (IMASH) A Randomized, Double-Blinded, Placebo-Controlled, Multicenter Phase III Trial
Publication in refereed journal

Times Cited
Web of Science123WOS source URL (as at 23/10/2020) Click here for the latest count
Altmetrics Information

Other information
AbstractBackground and Purpose-Pilot clinical trials using magnesium sulfate in patients with acute aneurysmal subarachnoid hemorrhage have reported trends toward improvement in clinical outcomes. This Phase III study aimed to compare intravenous magnesium sulfate infusion with saline placebo among such patients.
All Author(s) ListWong GKC, Poon WS, Chan MTV, Boet R, Gin T, Ng SCP, Zee BCY
Journal nameStroke
Volume Number41
Issue Number5
PublisherAmerican Heart Association
Pages921 - 926
LanguagesEnglish-United Kingdom
Keywordsaneurysm; intracranial aneurysm; magnesium; subarachnoid hemorrhage
Web of Science Subject CategoriesCardiovascular System & Cardiology; Clinical Neurology; CLINICAL NEUROLOGY; Neurosciences & Neurology; Peripheral Vascular Disease; PERIPHERAL VASCULAR DISEASE

Last updated on 2020-24-10 at 00:54